rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors von Li, Dan, Liang, Tianyuzhou, Hutchins, Laura E, Wolfarth, Alexandra A, Ferrando-Martinez, Sara, Lee, Byung Ha, Ho, Mitchell

Volltext

Mcc1229, an Stx2a-Amplifying Microcin, Is Produced In Vivo and Requires CirA for Activity von Nawrocki, Erin M, Hutchins, Laura E, Eaton, Kathryn A, Dudley, Edward G

Volltext

Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma : a southwest oncology group trial von MARGOLIN, K. A, LIU, P. Y, WEISS, G. R, SONDAK, V. K, UNGER, J. M, FLETCHER, W. S, FLAHERTY, L. E, URBA, W. J, HERSH, E. M, HUTCHINS, L. E, SOSMAN, J. A, SMITH, J. W

Volltext

Phase II trial of biochemotherapy with interferon [alpha], dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial von Margolin, Kim A, Liu, P Y, Unger, Joseph M, Fletcher, William S, Flaherty, Lawrence E, Urba, Walter J, Hersh, Evan M, Hutchins, Laura E, Sosman, Jeffrey A, Smith, John W, Weiss, Geoffrey R, Sondak, Vernon K

Volltext

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609 von Tarhini, Ahmad A, Lee, Sandra J, Hodi, F Stephen, Rao, Uma N M, Cohen, Gary I, Hamid, Omid, Hutchins, Laura F, Sosman, Jeffrey A, Kluger, Harriett M, Eroglu, Zeynep, Koon, Henry B, Lawrence, Donald P, Kendra, Kari L, Minor, David R, Lee, Carrie B, Albertini, Mark R, Flaherty, Lawrence E, Petrella, Teresa M, Streicher, Howard, Sondak, Vernon K, Kirkwood, John M

Volltext

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-3... von MAMOUNAS, Eleftherios P, JEONG, Jong-Hyeon, PAJON, Eduardo R, VOGEL, Victor G, KROENER, Joan F, HUTCHINS, Laura F, ROBIDOUX, André, HOEHN, James L, INGLE, James N, GEYER, Charles E, COSTANTINO, Joseph P, WOLMARK, Norman, WICKERHAM, D. Lawrence, SMITH, Roy E, GANZ, Patricia A, LAND, Stephanie R, EISEN, Andrea, FEHRENBACHER, Louis, FARRAR, William B, ATKINS, James N

Volltext

Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype von Julson, Janet R., Quinn, Colin H., Bownes, Laura V., Hutchins, Sara C., Stewart, Jerry E., Aye, Jamie, Yoon, Karina J., Beierle, Elizabeth A.

Volltext

PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4 von Marayati, Raoud, Julson, Janet, Bownes, Laura V., Quinn, Colin H., Stafman, Laura L., Beierle, Andee M., Markert, Hooper R., Hutchins, Sara C., Stewart, Jerry E., Crossman, David K., Hjelmeland, Anita B., Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.

Volltext

Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897 von HERSHMAN, Dawn L, UNGER, Joseph M, BARLOW, William E, HUTCHINS, Laura F, MARTINO, Silvana, KENT OSBORNE, C, LIVINGSTON, Robert B, ALBAIN, Kathy S

Volltext

Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs von He, Yi, Pavanello, Chiara, Hutchins, Patrick M, Tang, Chongren, Pourmousa, Mohsen, Vaisar, Tomas, Song, Hyun D, Pastor, Richard W, Remaley, Alan T, Goldberg, Ira J, Costacou, Tina, Sean Davidson, W, Bornfeldt, Karin E, Calabresi, Laura, Segrest, Jere P, Heinecke, Jay W

Volltext

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma von Bownes, Laura V, Marayati, Raoud, Quinn, Colin H, Beierle, Andee M, Hutchins, Sara C, Julson, Janet R, Erwin, Michael H, Stewart, Jerry E, Mroczek-Musulman, Elizabeth, Ohlmeyer, Michael, Aye, Jamie M, Yoon, Karina J, Beierle, Elizabeth A

Volltext

Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK) von Bownes, Laura V., Marayati, Raoud, Quinn, Colin H., Hutchins, Sara C., Stewart, Jerry E., Anderson, Joshua C., Willey, Christopher D., Datta, Pran K., Beierle, Elizabeth A.

Volltext

Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype von Marayati, Raoud, Julson, Janet R., Bownes, Laura V., Quinn, Colin H., Hutchins, Sara C., Williams, Adele P., Markert, Hooper R., Beierle, Andee M., Stewart, Jerry E., Hjelmeland, Anita B., Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.

Volltext

Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer von Mitrovic, Bojana, Handley, Kelly, Assarzadegan, Naziheh, Chang, Hector Li, Dawson, Heather A.E., Grin, Andrea, Hutchins, Gordon G.A., Magill, Laura, Quirke, Philip, Riddell, Robert H., Gray, Richard G, Kirsch, Richard

Volltext

Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A von DeGoey, David A., Randolph, John T., Liu, Dachun, Pratt, John, Hutchins, Charles, Donner, Pamela, Krueger, A. Chris, Matulenko, Mark, Patel, Sachin, Motter, Christopher E., Nelson, Lissa, Keddy, Ryan, Tufano, Michael, Caspi, Daniel D., Krishnan, Preethi, Mistry, Neeta, Koev, Gennadiy, Reisch, Thomas J., Mondal, Rubina, Pilot-Matias, Tami, Gao, Yi, Beno, David W. A., Maring, Clarence J., Molla, Akhter, Dumas, Emily, Campbell, Andrew, Williams, Laura, Collins, Christine, Wagner, Rolf, Kati, Warren M.

Volltext

Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders von Riazifar, Milad, Mohammadi, M. Rezaa, Pone, Egest J, Yeri, Ashish, Lässer, Cecilia, Segaliny, Aude I, McIntyre, Laura L, Shelke, Ganesh Vilas, Hutchins, Elizabeth, Hamamoto, Ashley, Calle, Erika N, Crescitelli, Rossella, Liao, Wenbin, Pham, Victor, Yin, Yanan, Jayaraman, Jayapriya, Lakey, Jonathan R. T, Walsh, Craig M, Van Keuren-Jensen, Kendall, Lotvall, Jan, Zhao, Weian

Volltext

Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, No... von HUTCHINS, Laura F, GREEN, Stephanie J, RAVDIN, Peter M, LEW, Danika, MARTINO, Silvana, ABELOFF, Martin, LYSS, Alan P, ALLRED, Craig, RIVKIN, Saul E, OSBORNE, C. Kent

Volltext

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis von Tarhini, Ahmad A, Kang, Ni, Lee, Sandra J, Hodi, F Stephen, Cohen, Gary I, Hamid, Omid, Hutchins, Laura F, Sosman, Jeffrey A, Kluger, Harriet M, Eroglu, Zeynep, Koon, Henry B, Lawrence, Donald P, Kendra, Kari L, Minor, David R, Lee, Carrie B, Albertini, Mark R, Flaherty, Lawrence E, Petrella, Teresa M, Streicher, Howard, Sondak, Vernon K, Kirkwood, John M

Volltext

Molecular Determinants of Species-Specific Activation or Blockade of TRPA1 Channels von Chen, Jun, Zhang, Xu-Feng, Kort, Michael E, Huth, Jeffrey R, Sun, Chaohong, Miesbauer, Laura J, Cassar, Steven C, Neelands, Torben, Scott, Victoria E, Moreland, Robert B, Reilly, Regina M, Hajduk, Philip J, Kym, Philip R, Hutchins, Charles W, Faltynek, Connie R

Volltext

Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials von UNGER, Joseph M, COLTMAN, Charles A, ALBAIN, Kathy S, CROWLEY, John J, HUTCHINS, Laura F, MARTINO, Silvana, LIVINGSTON, Robert B, MACDONALD, John S, BLANKE, Charles D, GANDARA, David R, CRAWFORD, E. David

Volltext